Suppr超能文献

[角膜细胞疗法——概述]

[Corneal cell therapy-an overview].

作者信息

Fuest M, Yam G Hin-Fai, Peh G Swee-Lim, Walter P, Plange N, Mehta J S

机构信息

Klinik für Augenheilkunde, Uniklinik RWTH Aachen, Pauwelsstr. 30, 52074, Aachen, Deutschland.

Tissue Engineering and Stem Cell Group, Singapore Eye Research Institute, Singapur, Singapur.

出版信息

Ophthalmologe. 2017 Aug;114(8):705-715. doi: 10.1007/s00347-017-0454-6.

Abstract

In recent years, the cultivation and expansion of primary corneal cells has made significant progress. The transplantation of cultured limbal epithelial cells represents a successful and established treatment of the ocular surface. Cultivated corneal endothelial cells are undergoing a clinical trial in Japan. Stromal keratocytes can now be expanded in vitro. A wide range of stem cell sources is being tested in vitro and animal models for their possible application in corneal cell therapy. This article gives an overview of recent advancements and prevailing limitations for the use of different cell sources in the therapy of corneal disease.

摘要

近年来,原代角膜细胞的培养与扩增取得了显著进展。培养的角膜缘上皮细胞移植是一种成功且成熟的眼表治疗方法。培养的角膜内皮细胞正在日本进行临床试验。基质角膜细胞现在可以在体外扩增。多种干细胞来源正在体外和动物模型中进行测试,以评估它们在角膜细胞治疗中的潜在应用。本文概述了在角膜疾病治疗中使用不同细胞来源的最新进展和当前存在的局限性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验